Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study - Castaigne, S; Pautas, C; Terré, C (Lancet Lond Engl, 2012)
et al.